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Background and purpose   The risk of revision due to infection 
after primary total hip arthroplasty (THA) has been reported to 
be increasing in Norway. We investigated whether this increase 
is a common feature in the Nordic countries (Denmark, Finland, 
Norway, and Sweden). 
Materials and methods   The study was based on the Nordic 
Arthroplasty Register Association (NARA) dataset. 432,168 pri-
mary THAs from 1995 to 2009 were included (Denmark: 83,853, 
Finland 78,106, Norway 88,455, and Sweden 181,754). Adjusted 
survival analyses were performed using Cox regression models 
with revision due to infection as the endpoint. The effect of risk 
factors such as the year of surgery, age, sex, diagnosis, type of 
prosthesis, and ﬁxation were assessed. 
Results   2,778 (0.6%) of the primary THAs were revised due 
to infection. Compared to the period 1995–1999, the relative 
risk (with 95% CI) of revision due to infection was 1.1 (1.0–1.2) 
in 2000–2004 and 1.6 (1.4–1.7) in 2005–2009. Adjusted cumula-
tive 5–year revision rates due to infection were 0.46% (0.42–
0.50) in 1995–1999, 0.54% (0.50–0.58) in 2000–2004, and 0.71% 
(0.66–0.76) in 2005–2009. The entire increase in risk of revision 
due to infection was within 1 year of primary surgery, and most 
notably in the ﬁrst 3 months. The risk of revision due to infection 
increased in all 4 countries. Risk factors for revision due to infec-
tion were male sex, hybrid ﬁxation, cement without antibiotics, 
and THA performed due to inﬂammatory disease, hip fracture, 
or femoral head necrosis. None of these risk factors increased in 
incidence during the study period.
Interpretation   We found increased relative risk of revision 
and increased cumulative 5–year revision rates due to infection 
after primary THA during the period 1995–2009. No change in 
risk factors in the NARA dataset could explain this increase. We 
believe that there has been an actual increase in the incidence of 
prosthetic joint infections after THA.
■
The outcome of hip replacement surgery and the survival of 
implants have improved during the last decades (Herberts 
and Malchau 2000, Liu et al. 2009, Fevang et al. 2010). How-
ever, an increase in the risk of revision due to infection after 
THA has also been reported in recent years (Kurtz et al. 2008, 
Dale et al. 2009, Pedersen et al. 2010b). We wanted to assess 
whether the increase in risk of revision due to infection is a 
common feature in the Nordic countries, and we therefore 
assessed time trends and risk factors for revision due to infec-
tion after primary total hip arthroplasty (THA) in the Nordic 
countries (Denmark, Finland, Norway, and Sweden). The aim 
was to compare revision rates due to infection in different 
time periods and different patient and implant groups, and to 
investigate factors that inﬂuence the risk of revision due to 
infection. 
Materials and methods
The Nordic Arthroplasty Register Association dataset
The NARA dataset contains merged individual-based data from 
the Danish, Finnish, Norwegian, and Swedish arthroplasty reg-
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459,540 primary arthroplasties in the NARA dataset, 7,450 
resurfacing arthroplasties were not considered as THAs. Of 
the 452,090 THAs, 3,397 were excluded due to unknown type 
of ﬁxation, as were 16,525 THAs due to incomplete infor-
mation on the risk factors. 432,168 THAs met the inclusion 
criteria. Denmark contributed 83,853 primary THAs, Finland 
78,106, Norway 88,455, and Sweden 181,754 (Table 1).
Statistics
Descriptive statistics were used for presentation of the patient 
and procedure characteristics. Adjusted Cox regression analy-
ses were performed to assess relative risk of revision due to 
infection and to estimate adjusted cumulative 5-year prob-
ability (risk) of revision. Unadjusted cumulative 5-year risks 
of revision due to infection were estimated by the Kaplan-
Meier (KM) method. The study population was divided into 
5-year periods (1995–1999, 2000–2004, and 2005–2009). The 
cases were observed until ﬁrst revision, death, emigration, or 
December 31, 2010. We also investigated changes in the revi-
sion rates due to deep infection as a function of the year of 
operation, to give a graphical display of the relationship based 
on a generalized additive model for survival data (Hastie and 
Tibshirani 1990). Adjusted hazard rate ratios, as a measure of 
relative risk, were estimated, with 95% conﬁdence intervals 
(CIs) for time periods and risk factors. In the Cox analyses we 
adjusted for age, sex, diagnosis, modularity of the prosthesis, 
and ﬁxation, and the inﬂuence on revision risk of each of these 
factors was assessed. Separate Cox analyses were performed 
on a homogenous subgroup of hips with cemented modular 
THAs with antibiotics in the cement on patients with OA, as 
this combination was common throughout the 3 time periods 
in all 4 countries. 
The Cox survival analyses were performed with 1–16 years 
of follow-up, but the last time period had only 1–6 years of 
follow-up. To ensure that there was similar follow-up for oper-
ations in all 3 time periods, we performed additional analyses 
with follow-up restricted to 1–6 years for each time period. In 
addition, we performed separate time trend analyses of revi-
sion due to infection for men and women, all age groups, and 
groups of diagnoses separately. Also, the risk factors were 
studied in each country separately. Finally, we assessed the 
risk factors separately within each of the 3 time periods to 
Table 1. Patient and procedure characteristics for the primary THAs included, and 
number of primary THAs excluded over the 3 time periods
 
 1995–1999 2000–2004 2005–2009 1995–2009
Number of THAs included 113,280 147,823 171,065 432,168
Age (%)
   <40 years  2 1 1 1
   40–59 years 17 18 17 17
   60–69 years 29 29 32 30
   70–79 years 38 37 35 36
   80–89 years 14 15 15 15
   *90 years 1 1 1 1
Sex (%) Female 63 62 61 61
Diagnosis (%)
   Osteoarthritis 76 80 83 80
   Hip fracture 10 7 6 8
   Inﬂammatory disease 5 4 2 4
   Childhood hip disease 4 4 3 3
   Femoral head necrosis 2 2 2 2
   Other diagnoses 2 3 3 3
Prosthesis (%) 
   Monoblock 22 10 2 10
   Modular 78 90 98 90
Fixation (%)
   Uncemented 13 16 30 21
   Cemented 76 71 56 67
   Hybrid 10 10 6 9
   Inverse hybrid 1 3 8 4
Cement (%) 
   No cement 13 16 30 21
   With antibiotics 71 79 69 73
   Without antibiotics 15 5 1 6
Country (%)
   Denmark 14 20 22 21
   Norway 23 21 19 20
   Sweden 45 42 41 42
   Finland  19 17 18 18
Number of THAs excluded 10,540 3,303 6,169  9,922 (4.4%)
isters (Herberts et al. 1989, Havelin et al. 2000, 
Lucht 2000, Puolakka et al. 2001, Malchau et 
al. 2005, Havelin et al. 2009). In each register, 
the data selected were transformed according to 
a common set of deﬁnitions, and revisions were 
linked to the primary procedures. The data were 
de-identiﬁed nationally before the anonymous 
data were merged into the NARA dataset. The 
data were treated in full conﬁdentiality and in 
compliance with the regulations of each country 
(Havelin et al. 2009).
The inclusion criteria in the present study 
were primary THAs and ﬁrst revisions from 
the period 1995 through 2009, with complete 
information on the following parameters: year 
of primary surgery and ﬁrst revision, age, sex, 
diagnosis (osteoarthrosis (OA), inﬂammatory 
hip disease, hip fracture, childhood hip disease, 
femoral head necrosis, or other diagnoses), pros-
thesis (monoblock or modular), and type of ﬁxa-
tion (uncemented, cemented, hybrid, or inverse 
hybrid, with plain or antibiotic-loaded cement). 
Primary THA was deﬁned as the ﬁrst total hip 
prosthesis regardless of cause of the arthroplasty. 
The endpoint was revision due to infection, and 
revision was deﬁned as removal or exchange 
of the whole or part(s) of the prosthesis. Infec-
tion as the cause of revision was determined 
and reported by the surgeon immediately after 
surgery, based on the preoperative clinical mani-
festations and samples in addition to peropera-
tive evaluation. The national datasets were har-
monized according to these deﬁnitions. Of the 
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minimize time-dependent confounding. Additional Cox anal-
yses with the endpoints revision due to aseptic loosening and 
revision for any cause were performed to relate these to our 
ﬁndings on revision due to infection. 
The analyses were performed in accordance with the guide-
lines for statistical analyses of arthroplasty register data 
(Ranstam et al. 2011). The proportional-hazard assumptions 
of the Cox survival analyses were not completely fulﬁlled. We 
therefore assessed the proportionality of the main risk factors 
by smoothed Schoenfeld residuals (Figure 3) (Ranstam et al. 
2011). This resulted in assessment of the risk factors before 
and after 1 year, since adjusted revision rates of the 3 time 
periods were not fully proportional. Potential overestimation 
of incidence of revision due to infection through the effect of 
competing risks (death and revision due to causes other than 
infection) was assessed by the cumulative incidence function 
(Gillam et al. 2010). The 3.9% of THAs that were revised for 
causes other than infection and the 21% of THA patients who 
died during the follow-up had a negligible effect on the Cox 
analyses.
Bilateral THAs are not independent observations, but were 
included. The extent of bilaterality was estimated to be 18% 
and the incidence of revision due to infection was 0.6% in 
both the ﬁrst and second hip. Only 0.05% of the bilateral 
THAs were identiﬁed to have had revisions due to infection 
in both hips. We therefore considered bilaterality to have a 
negligible inﬂuence on the results (Lie et al. 2004, Ranstam 
and Robertsson 2010, Ranstam et al. 2011). 
Values of p < 0.05 were considered to be statistically signiﬁ-
cant. SPSS software version 18.0 and the R statistical software 
package were used for the analyses.
Results
2,778 primary THAs (0.6%) were revised due to deep infec-
tion. The cumulative 5-year revision rate due to infection, 
adjusted for year of primary surgery, was 0.62% (0.60–0.65) 
for the study population and 0.99% (0.83–1.15) for the 
excluded THAs (4.4% of the total). The implants at use had 
changed during the study period. In the last 5-year period, there 
were more uncemented THAs and inverse hybrid THAs and 
nearly all of the cemented THAs were modular and inserted 
with cement containing antibiotics (Table 1). There were only 
minor changes in the distribution of patient-related risk fac-
tors over the study period, with the exception that fewer THAs 
were performed due to inﬂammatory disease and hip fracture 
later in the study period (Table 1).
Time trend of revision due to infection
The risk of revision due to infection increased in the period 
2005–2009 relative to the period 1995–1999 in the total 
study population (Table 2; Figures 1 and 2), and in each of 
the 4 countries separately (Denmark: RR = 1.3 (CI 1.0–1.6); 
Norway: RR = 1.7 (1.2–2.3); Sweden: RR = 1.5 (1.2–1.9); 
and Finland: RR = 1.2 (1.0–1.5)). For the period 2000–2004, 
the risk of revision due to infection only increased in Norway 
(RR = 1.3 (1.1–1.6)). The overall cumulative 5-year revision 
rate due to infection also increased, despite the fact that the 
revision rate for the period 2005–2009 might be an underesti-
mate due to incomplete 5-year follow-up (Table 3 and Figure 
1). The subgroup of cemented modular THAs with antibiotic-
loaded bone cement in OA patients showed similar results 
(Tables 2 and 3; Figures 1 and 2). 
Table 2. Relative risk of revision due to infection of primary THAs in the NARA with 1–16 years of follow–up. 
Adjusted for age, sex, diagnosis, prosthesis, and cement
  Number Number of Adjusted risk ratio 95% 
  of THAs THAs revised for revision conﬁdence
 Period included due to infection due to infection interval p–value
All THAs 1995–1999 113,280 778 1
 2000–2004 147,823 937 1.1 1.0–1.2 0.03
 2005–2009 171,065 1,063 1.6 1.4–1.7 <0.001
Uncemenxted THAs 1995–1999 15,177 87 1
 2000–2004 23,553 147 1.4 1.0–1.8 0.03
 2005–2009 51,445 308 1.9 1.5–2.5 <0.001
Cemented THAs 1995–1999 86,177 538 1
 2000–2004 105,421 641 1.2 1.1–1.3 0.006
 2005–2009 96,455 619 1.7 1.5–2.0 <0.001
Hybrid THAs 1995–1999 11,369 149 1
 2000–2004 15,163 125 0.8 0.6–1.0 0.02
 2005–2009 10,390 63 0.8 0.6–1.1 0.2
Inverse hybrid THAs 1995–1999 556 4 1
 2000–2004 3,685 24 1.3 0.4–4.0 0.6
 2005–2009 12,775 73 1.6 0.5–4.6 0.4
Cemented modular THAs 1995–1999 37,848 208 1
with antibiotics in cement 2000–2004 69,052 374 1.1 0.9–1.3 0.2
inserted due to OA a 2005–2009 75,929 467 1.7 1.4–2.0 <0.001
a Adjusted for age and sex.
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The entire increase in risk of revision due to infection 
occurred within 1 year of primary surgery, and most nota-
bly within the ﬁrst 3 months after surgery (Table 4; Figures 
1 and 3). The increased risk of revision due to infection was 
found for cemented and uncemented THAs, but not for hybrid 
THAs and inverse hybrid THAs (Table 2; Figures 1 and 2). 
The increase in risk of revision due to infection was more 
gradual through the time periods for uncemented THAs than 
for cemented THAs, where the main increase in relative risk 
of revision and cumulative 5-year revision rate was in the last 
time period (Tables 2 and 3; Figures 1 and 2). 
The risk of revision due to infection increased similarly 
for men and women, in all age groups and for the different 
within each time period separately and before and after 1 year 
after primary surgery. The exception was patients of advanced 
age at primary THA, who had a higher risk of revision due 
to infection within the ﬁrst year after surgery, whereas they 
had a lower risk of revision due to infection more than 1 year 
postoperatively.
Discussion
Our main ﬁnding was the higher risk of revision due to infec-
tion after primary uncemented and cemented THAs in the 4 
Nordic countries for the period 2005–2009 than for the period 
Figure 1. Adjusted cumulative revision rates for THAs revised due to infection in 3 time periods of 
primary surgery, for all THAs (upper left panel) and 5 subgroups of THAs. Adjusted for age, sex, 
diagnosis, prosthesis, and cement. *Adjusted for age and sex only.
diagnoses, as well as for the excluded 
cases.
Time trend of revision due to 
aseptic loosening and revision 
for any cause
The adjusted cumulative 5-year revi-
sion rate due to aseptic loosening was 
lower in 2000–2004 and 2005–2009 
than in 1995–1999, but the last time 
period did not have complete 5-year 
follow-up and would have been an 
underestimate (Table 3). For unce-
mented THAs, the cumulative 5-year 
revision rate due to aseptic loosen-
ing did not improve during the study 
period (Table 3). For revisions due 
to any cause, there was no improve-
ment in cumulative 5-year revision 
rate during the study period, except 
for hybrid THA, despite the incom-
plete 5-year follow-up in 2005–2009 
(Table 3). Compared to other meth-
ods of ﬁxation, cemented THA had 
the lowest cumulative 5-year revi-
sion rate for any cause in 2005–2009 
(Table 3).
Risk factors for revision due to 
infection
Male sex and THA performed due to 
inﬂammatory disease, hip fracture, 
or femoral head necrosis were the 
patient-related risk factors associated 
with increased risk of revision due to 
infection (Table 5). Implant-related 
risk factors that increased the relative 
risk of revision due to infection were 
hybrid ﬁxation and plain bone cement 
(Table 5). The ﬁndings were similar 
when we assessed the risk factors 
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1995–1999. This conﬁrms earlier reports from Norway and 
Denmark (Dale et al. 2009, Pedersen et al. 2010b). The cumu-
lative 5-year revision rate due to infection was also higher in 
2005–2009 than in the previous 2 time periods. This was the 
case even though the revision rates for 2005–2009 probably 
were underestimates due to the incomplete 5-year follow-up, 
and they might therefore have been expected to be even higher.
None of the risk factors that we assessed could explain the 
increased risk of revision due to infection. The incidence of 
unfavorable risk factors (male sex, hybrid ﬁxation, cement 
without antibiotics, and THA performed due to inﬂamma-
tory disease, hip fracture, or femoral head necrosis) did not 
increase during the study period. In addition, these confound-
ers were adjusted for in the analyses. An increased incidence 
type of systemic antibiotic prophylaxis are also not included 
in the NARA dataset. However, both short and long duration 
of surgery have been shown to be risk factors for infection 
(Ridgeway et al. 2005, Pulido et al. 2008, Dale et al. 2009, 
Pedersen et al. 2010b, Dale et al. 2011). Less compliance to 
guidelines for optimal systemic prophylaxis could also have 
contributed to an increased incidence of prosthetic joint infec-
tions, as could an increase in bacterial resistance to antibiotic 
prophylaxis (Kerttula et al. 2007, Stefansdottir et al. 2009a, b, 
Lutro et al. 2010). Finally, changes in operation room ventila-
tion or changed adherence to guidelines of prophylactic rou-
tines may also have inﬂuenced the trend of revision due to 
infection (National Institute of Health and Clinical Excellence 
(NICE) 2008, Dale et al. 2009). 
Figure 2. Graphical display of the relationship between year of primary surgery and relative risk of 
revision due to infection (with 95% CI), for all THAs (upper left panel) and 5 subgroups of THAs. 
The broken lines represent no difference in relative risk from the beginning of the period (RR = 1). 
Adjusted for age, sex, diagnosis, prosthesis, and cement. *Adjusted for age and sex.
of prosthetic joint infection would 
therefore have to be caused by factors 
that are not registered in the NARA 
dataset. These may include changes 
in patient-related factors (i.e. more 
comorbidity), changes in microbiol-
ogy (i.e. increased bacterial virulence 
or more resistant strains), or changes 
in surgery-related factors (i.e. dura-
tion of surgery or changed surgical 
technique).
The common NARA dataset con-
tains only limited information on 
comorbidity, which is a well-docu-
mented risk factor for infection after 
THA (Ridgeway et al. 2005, Pulido et 
al. 2008, Pedersen et al. 2010b, Dale 
et al. 2011). If THA was performed 
on more patients with poor health in 
the later parts of the study period, an 
increased incidence of prosthetic joint 
infections could result. In Norway, 
the comorbidity at THA increased 
during 2005–2009 (The Norwegian 
Arthroplasty Register 2010). The 
incidence of speciﬁc comorbidi-
ties associated with increased risk 
of infection after THA, like obesity 
and diabetes, is increasing in sev-
eral countries (Pedersen et al. 2010a, 
Danaei et al. 2011, Haverkamp et 
al. 2011, Mraovic et al. 2011, Doak 
et al. 2012, Iorio et al. 2012). Given 
that the THA patients reported to the 
NARA are representative of the gen-
eral population, an increased inci-
dence of prosthetic joint infections 
requiring revision could result.
Surgery-related risk factors such as 
duration of surgery, and timing and 
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Other confounders not reported to the NARA may have con-
tributed to an increase in reporting of revision due to infection 
to the registers without reﬂecting a corresponding increase in 
true incidence of prosthetic joint infection. Such confound-
ers could be improved reporting of revisions due to infection, 
changes in revision policy and in the threshold of revision 
(i.e. new surgical methods), or changes in diagnostics (i.e. 
improved microbiological detection methods and changed 
the reason for the increased risk of revision due to infection 
in the ﬁrst year after primary surgery, as found for the latter 
2 time periods. In addition, similar operations performed on 
monoblock prostheses would not be reported because heads 
and liners were not exchanged. We adjusted for this poten-
tial under-reporting of infected monoblock prostheses in the 
analyses. In addition, the minor partial revisions were most 
likely used as alternatives to complete exchange procedures 
Table 3. Adjusted cumulative 5-year revision rates of primary THAs in the NARA. Adjusted for age, sex, diagnosis, prosthesis, and cement
   Cumulative 5-years revision rate
  Number
  of THAs Kaplan–Meier Adjusted Adjusted Adjusted
 Period included infection infection aseptic loosening all revisions
All THAs 1995–1999 113,280 0.54 (0.49–0.58) 0.46 (0.42–0.50) 1.41 (1.34–1.49) 3,34 (3.22–3.45)
 2000–2004 147,823 0.57 (0.53–0.61) 0.54 (0.50–0.58) 0.81 (0.77–0.86) 3.01 (2.92–3.10)
 2005–2009 b 171,065 0.73 (0.68–0.77) 0.71 (0.66–0.76) 1.00 (0.93–1.07) 3.30 (3.19–3.41)
Uncemented THAs 1995–1999 15,177 0.36 (0.26–0.45) 0.34 (0.25–0.44) 1.32 (1.13–1.50) 4.39 (4.05–4.72)
 2000–2004 23,553 0.55 (0.45–0.65) 0.52 (0.43–0.61) 0.85 (0.73–0.97) 4.28 (4.02–4.54)
 2005–2009 b 51,445 0.70 (0.61–0.78) 0.65 (0.57–0.74) 1.21 (1.08–1.34) 4.24 (4.02–4.45)
Cemented THAs 1995–1999 86,177 0.51 (0.47–0.56) 0.43 (0.38–0.48) 1.34 (1.25–1.43) 2.82 (2.70–2.94)
 2000–2004 105,421 0.56 (0.51–0.60) 0.52 (0.48–0.57) 0.74 (0.68–0.79) 2.53 (2.43–2.63)
 2005–2009 b 96,455 0.74 (0.68–0.81) 0.74 (0.67–0.80) 0.85 (0.77–0.94) 2.93 (2.80–3.07)
Hybrid THAs 1995–1999 11,369 0.94 (0.76–1.12) 0.88 (0.70–1.06) 1.82 (1.55–2.09) 4.92 (4.50–5.34)
 2000–2004 15,163 0.72 (0.58–0.85) 0.67 (0.53–0.80 0.98 (0.81–1.14) 3.79 (3.48–4.10)
 2005–2009 b 10,390 0.72 (0.54–0.90) 0.67 (0.50–0.85) 1.00 (0.75–1.25) 3.86 (3.41–4.31)
Inverse hybrid THAs 1995–1999 556 0.77 (0.02–1.51) 0.36 (0–1.38) 2.36 (0.97–3.75 5.59 (3.65–7.54)
 2000–2004 3,685 0.53 (0.29–0.77) 0.34 (0–1.27) 1.64 (1.19–2.09) 3.98 (3.31–4.64)
 2005–2009 b 12,775 0.66 (0.50–0.83) 0.43 (0–1.58) 1.37 (1.02–1.72) 3.67 (3.20–4.14)
Modular THAs with 1995–1999 37,848 0.43 (0.36–0.49) 0.40 (0.33–0.46) 1.18 (0.67–1.69) 2.60 (2.44–2.77)
antibiotics in cement 2000–2004 69,052 0.49 (0.44–0.55) 0.47 (0.41–0.52) 0.69 (0.39–0.99) 2.21 (2.10–2.32)
in patients with OAa 2005–2009 b 75,929 0.71 (0.64–0.77) 0.67 (0.60–0.73) 0.78 (0.44–1.12) 2.60 (2.46–2.75) 
a Adjusted for age and sex.
b Cumulative 5-year revision rates probably were underestimates due to incomplete 5-year follow-up.
Table 4. Adjusted relative risks of revision due to infection for 4 different time intervals after pri-
mary surgery, for the 3 time periods. Adjusted for age, sex, diagnosis, prosthesis, and cement
 Number Number of Adjusted risk ratio
Time after of THAs THAs revised for revision 
primary surgery included due to infection due to infection 95% CI p–value
0–3 months 
 1995–1999 113,280 74 1  
 2000–2004 147,823 175 1.9 1.4–2.4 <0.001
 2005–2009 171,065 535 4.8 3.7–6.2 <0.001
3–12 months 
 1995–1999 111,607 142 1  
 2000–2004 145,625 206 1.3 1.0–1.6 0.05
 2005–2009 168,019 216 1.2 1.0–1.5 0.09
1–2 years 
 1995–1999 109,178 164 1  
 2000–2004 142,589 195 1.1 0.9–1.3 0.6
  2005–2009 164,758 175 1.0 0.8–1.3 0.9
> 2 years 
 1995–1999 105,338 398 1    
 2000–2004 138,270 361 0.9 0.8–1.1 0.5
  2005–2009 126,131 137 0.9 0.7–1.1 0.2
deﬁnitions) (Dale et al. 2009, Ped-
ersen et al. 2010b). 
Since 2000, in Norway there has 
been an increase in the reporting of 
minor revision procedures, such as 
soft tissue debridement procedures 
with exchange of removable parts 
of modular implants and retention 
of the femoral stem and acetabu-
lar cup (Engesæter et al. 2011). 
Such procedures were reported 
to the registers as revision pro-
cedures because prosthesis parts 
were exchanged. These minor 
revisions may have different indi-
cations or a lower threshold to be 
performed than full exchange revi-
sions. Such minor revisions may 
also be performed and reported 
earlier postoperatively than full 
exchange revisions. This may be 
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rather than alternatives to no revision at all. This is supported 
by the ﬁnding of a higher risk of revision due to infection 
in 2005–2009 than in 1995–1999 both for the uncemented 
THAs, which were all modular, and for the more homogenous 
subgroup of modular THAs inserted with cement containing 
may also have increased the number of infections being iden-
tiﬁed preoperatively (Trampuz and Widmer 2006, Moojen et 
al. 2007). The clinical presentation of an aseptic loosening 
and a low-grade periprosthetic infection may also be similar 
(Tunney et al. 1998, Ince et al. 2004, Moojen et al. 2010). If 
Figure 3. A graphical display of the relationship between relative risk of revision due to infection and 
time after primary THAs for the period 2000–2004 (left panel) and 2005–2009 (right panel) compared 
to 1995–1999 (blue lines). Smoothed Schoenfeld residuals adjusted for age, sex, diagnosis, prosthe-
sis and cement (solid lines) with 95% conﬁdence intervals (broken lines).
antibiotics in patients with OA. In 
addition, in Norway the incidence 
of major revision due to infection 
increased during 1995–2009 as 
well (Engesæter et al. 2011). Thus, 
we do not think that increased 
use of modular implants and the 
changes in revision policy could 
explain the increased risk of revi-
sion due to infection.
There have been improvements 
in the diagnostics of prosthetic 
joint infections. Some bacteria 
such as coagulase-negative staph-
ylococci have been increasingly 
acknowledged for their pathoge-
nicity (von Eiff et al. 2006). In 
addition, improvements in bacte-
rial sampling and identiﬁcation 
Table 5. Adjusted relative risks and adjusted cumulative 5–year revision rates for risk factors for revision due to infection. All 
risk factors were adjusted mutually for the other risk factors in addition to the year of primary surgery. Follow–up in the risk 
analyses was 1–16 years
  Number Number of Adjusted risk ratio 95%   Adjusted cumulative
  of THAs THAs revised for revision conﬁdence  5-years revision rate,
  included due to infection due to infection interval p–value infection
Age (years)
   <40 5,590 39 1   0.47
   40–51 74,107 515 1.1 0.8–1.5 0.6 0.59
   60–69 129,134 854 1.1 0.8–1.5 0.7 0.58
   70–79 157,292 1,021 1.1 0.8–1.5 0.6 0.62
   80–89 63,034 337 0.9 0.7–1.3 0.8 0.52
   *90 3,011 12 0.7 0.4–1.4 0.3 0.32
Sex
   Female 266,42 1,312 1   0.46
   Male 165,748 1,466 1.9 1.8–2.1 <0.001 0.87
Diagnosis 
   Osteoarthritis 345,925 2,090 1   0.54
   Hip fracture 33,572 327 2.1 1.9–2.4 <0.001 1.12
   Inﬂammatory disease 15,771 118 1.4 1.1–1.7 0.001 0.72
   Childhood hip disease 14,983 80 0.9 0.7–1.2 0.6 0.51
   Femoral head necrosis 9,671 92 1.7 1.4–2.1 <0.001 0.87
   Other diagnoses 12,246 71 1.3 1.0–1.6 0.06 0.65
Prosthesis
   Modular 388,371 2,475 1   0.58
   Monoblock 43,797 303 1.1 1.0–1.3 0.09 0.69
Fixation
   Uncemented 90,177 542 1   0.54
   Cemented 288,053 1,798 1.1 1.0–1.2 0.09 0.58
   Hybrid 36,922 337 1.6 1.4–1.8 <0.001 0.79
   Inverse hybrid 17,016 101 1.0 0.8–1.3 0.7 0.53
Cement
   With antibiotics 316,072 1,997 1   0.58
   Without antibiotics 25,921 239 1.5 1.3–1.8 <0.001 0.96
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thetic joint infections in need of revision (Mannien et al. 2008, 
Health Protection Agency 2011).
A previous study from Norway found that uncemented 
THAs had a higher risk of revision due to infection than 
cemented THAs (Dale et al. 2009). A study from Denmark, in 
contrast, found that cemented THAs had higher risk of revi-
sion due to infection than uncemented THAs (Pedersen et al. 
2010b). In the present study, the overall risk of revision due to 
infection was similar for cemented, inverse hybrid, and unce-
mented THAs. 
We found an incidence of revision due to infection of 0.6%; 
it is therefore a relatively rare complication after THA. Large 
populations are required for the study of time trends and risk 
factors for such rare events. The large NARA dataset offers 
an opportunity for in-depth studies of revision due to infec-
tion even in subgroups with sufﬁcient power. The data are pro-
spective and have a high degree of completeness (Soderman 
et al. 2000, Pedersen et al. 2004, Espehaug et al. 2006). The 
completeness of the NARA dataset and the small proportion 
of cases excluded in the present study (4.4%) also indicate 
that there was minimal selection bias, even if the relative risk 
of revision due to infection was higher in the excluded group. 
The time trend of revision due to infection was similar for 
the included cases and the excluded cases. The number of 
variables in the NARA dataset is limited, however, and even 
though we adjusted for several well-known confounders in our 
analyses, unmeasured confounding would still be a problem. 
Considering the size and quality of the NARA dataset, and 
the adjustment for several clinically important risk factors, 
we believe that there has been a true increase in the risk of 
prosthetic joint infections. The largest increase in relative risk 
of revision due to infection was for uncemented THAs, but 
the overall risk of revision due to infection was similar for 
cemented, uncemented, and inverse hybrid THAs. Male sex, 
hybrid ﬁxation, cement without antibiotics, and THA per-
formed due to inﬂammatory disease, hip fracture, or femoral 
head necrosis were risk factors for revision due to infection. 
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of the manuscript. 
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there may have been a corresponding change in reporting of 
infection as the cause of the revision. Unexpectedly positive 
peroperative bacterial samples would be identiﬁed postopera-
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